Does global health funding respond to recipients' needs? Comparing public and private donors' allocations in 2005-2007

World Development

Volumn 39, Issue 8, 2011, Pages 1271-1280

  Esser, Daniel E ^a   Keating Bench, Kara ^b  

^a AMERICAN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aid effectiveness; Global health; HIV AIDS; Official development assistance; Private donors; Sub Saharan Africa

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPMENT AID; GLOBALIZATION; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 79960315547     PISSN: 0305750X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.worlddev.2010.12.005     Document Type: Article

References (42)

1. Anabwani G., Navario P. Nutrition and HIV/AIDS in sub-Saharan Africa: An overview. Nutrition 2005, 21(1):96-99.
2. Archibugi D., Bizzarri K. The global governance of communicable diseases: The case for vaccine R&D. Law and Policy 2005, 27(1):33-51.
3. Arneson T., Nord E. The value of DALY life: Problems with ethics and validity of disability adjusted life years. BMJ 1999, 319(7222):1423-1425.
4. Attaran A., Barnes K., Bate R., Binka F., d'Alessandro U., Fanello C., et al. The World Bank: False financial and statistical accounts and medical malpractice in malaria treatment. The Lancet 2006, 368:247-252.
5. Barnebeck Anderson T., Hansen H., Markussen T. US politics and World Bank IDA-lending. Journal of Development Studies 2006, 42(5):772-794.
6. Barrett S. Eradication versus control: The economics of global infectious disease policies. Bulletin of the World Health Organization 2004, 82(9):683-688.
7. Benatar S.R., Gill S., Bakker I. Making progress in global health: The need for new paradigms. International Affairs 2009, 85(2):347-371.
8. Buse K., Harmer A. Seven habits of highly effective global public-private health partnerships: Practice and potential. Social Science and Medicine 2007, 64(2):259-271.
9. Crane B., Dusenberry J. Power and politics in international funding for reproductive health: The US global gag rule. Reproductive Health Matters 2004, 12(24):128-137.
10. De Quadros C.A. The whole is greater: How polio was eradicated from the western hemisphere. The practice of international health 2009, 54-69. Oxford University Press, Oxford. D. Perlman, A. Roy (Eds.).
11. Dugger, C. W. (2009). As donors focus on AIDS, child illnesses languish. NY Times. Retrieved 29.10.09. http://www.nytimes.com.
12. Eichler R., Levine R. Performances incentives for global health: Potential and pitfalls 2009, The Performance-Based Incentives, Brookings Institution Press, Washington.
13. Esser D.E. More money, less cure: Why global health assistance needs restructuring. Ethics and International Affairs 2009, 23(3):225-234.
14. Foundation Directory Online (2008a). Grants database. Washington, DC: Foundation Center. Retrieved 16.05.08. http://foundationcenter.org/.
15. Foundation Directory Online (2008b). Top 50 US foundations awarding international grants for health. Washington, DC: Foundation Center. Retrieved 17.05.08. http://foundationcenter.org/findfunders/statistics/.
16. IEG Improving effectiveness and outcomes for the poor in health, nutrition, and population: An evaluation of World Bank Group support since 1997 2009, The World Bank Group, Washington, DC.
17. Jamison D.T., Breman J.G., Measham A.R., Alleyne G., Claeson M., Evans B., et al. Disease control priorities in developing countries 2006, Oxford University Press, New York. 2nd ed.
18. Kaiser Family Foundation (2007). A global look at public perceptions of health problems, priorities, and donors: The Kaiser/Pew global health survey. Menlo Park, CA: The Kaiser Family Foundation and Pew Global Attitudes Project, December. Retrieved 02.05.08. http://www.pewglobal.org.
19. Kates, J., & Lief, E. (2007). Donor funding for health in low- and middle-income countries 2001-2005. Menlo Park, CA: The Kaiser Family Foundation, August. Retrieved 01.05.08. http://www.kff.org.
20. Lethbridge J. The promotion of investment alliances by the World Bank: Implications for national health policy. Global Social Policy 2005, 5(2):203-225.
21. Lu C., Schneider M., Gubbins P., Leach-Kemon K., Jamison D., Murray C.J.L. Public financing of health in developing countries: A cross-national systematic analysis. The Lancet 2010, 375:1375-1387.
22. MacKellar L. Priorities in global assistance for health, AIDS, and population. Population and Development Review 2005, 31(2):293-312.
23. McMichael A.J., Beaglehole R. The changing global context of public health. The Lancet 2000, 356:495-499.
24. Michaud C., Murray C.J.L. External assistance to the health sector in developing countries: A detailed analysis 1972-1990. Bulletin of the World Health Organization 1994, 72:639-651.
25. Mason, M. (2009). AIDS, malaria eclipse biggest child-killers. Associated Press. 19 November.
26. Murray C.J.L., Lopez A.D. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global burden of disease and injury series 1996, Harvard School of Public Health/WHO/World Bank, Cambridge, MA.
27. OECD (2005). Paris declaration on aid effectiveness: Ownership, harmonization, alignment results, and mutual accountability. Paris: Organization for Economic Development and Cooperation, March. Retrieved 30.07.08. http://www.oecd.org.
28. The practice of international health 2009, Oxford University Press, Oxford. D. Perlman, A. Roy (Eds.).
29. Pearson S.D., Rawlings M.D. Quality, innovation, and value for money: NICE and the British National Health Service. JAMA 2005, 294(20):2618-2622.
30. Périn I., Attaran A. Trading ideology for dialogue: An opportunity to fix international aid for health?. The Lancet 2003, 361:1216-1219.
31. Powell-Jackson T., Borghi J., Mueller D., Patouillard E., Mills A. Countdown to 2015: Tracking donor assistance to maternal, newborn, and child health. The Lancet 2006, 368:1077-1087.
32. Ravishankar N., Gubbins P., Cooley R., Leach-Kemon K., Michaud M., Jamison D., et al. Financing global health: Tracking development assistance for health. The Lancet 2009, 373:2113-2124.
33. Political ethnography: What immersion contributes to the study of power 2009, University of Chicago Press, Chicago. E. Schatz (Ed.).
34. Sewell W.H. A theory of structure: Duality, agency, and transformation. The American Journal of Sociology 1992, 98(1):1-29.
35. Shiffman J. Donor funding priorities for communicable disease control in the developing world. Health Policy and Planning 2006, 21(6):411-420.
36. Shiffman J. Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy and Planning 2008, 23:95-100.
37. SourceOECD (2009). Creditor reporting system (CRS). Paris: Organization for Economic Cooperation and Development. Retrieved 12-13.05.09. http://www.oecd.org.
38. Sridhar D. Post-Accra: Is there space for country ownership in global health?. Third World Quarterly 2009, 30(7):1363-1377.
39. Sridhar D., Rajaie B. Misfinancing global health: A case for transparency in disbursements and decision making. The Lancet 2008, 372:1185-1191.
40. Waddington C. Does earmarked donor funding make it more or less likely that developing countries will allocate their resources towards programmes that yield the greatest health benefits?" Bulletin of the World Health Organization 2004, 82:703-708.
41. Walt G., Pavignani E., Gilson L., Buse K. Health sector development: From aid coordination to resource management. Health Policy and Planning 1999, 14(3):207-218.
42. WHO (2002). Global burden of disease estimates. Geneva: World Health Organization. Retrieved 3-6.05.08. http://www.who.int.